• Record A$5.1m in total contract value, highest quarterly result to date
• Signed 17 new client agreements, including major US healthcare institutions
• Continued cost discipline and efficiency, with ~US$2.5m in annualised cost savings

Enlitic Inc, a medical technology software company leveraging artificial intelligence to improve the management and utility of medical imaging data, reported a strong Q1 FY26 with record contract wins totalling A$5.1m, the highest quarterly result to date. The company signed 17 new client agreements, including notable contracts with Penn Medicine, St. Jude Children's Research Hospital, and Parkland Health. These contracts serve a dual purpose, delivering immediate project revenue while creating the potential for Enlitic's Ensight data management platform to be deployed into an expanding installed customer base. The Parkland Health contract, valued at US$1.2m, integrates Ensight into the migration process and has expansion potential to cover up to 13 million imaging studies. Enlitic continued to demonstrate cost discipline, implementing further measures to deliver ~US$2.5m in annualised cost savings. The company's cash balance at the end of the quarter was US$2.97m, boosted by the completion of a A$5.4m convertible note raise. With A$5.1m in new contract value and US$2.5m in receivables, Enlitic expects revenue to build as project delivery progresses and Ensight deployments commence across the installed migration base.

The company's OEM relationships, including its binding MOU with GE Healthcare, continue to support the forward pipeline. Enlitic expects revenue to build as project delivery progresses and Ensight deployments commence across the installed migration base, supporting its progress to expected operational cashflow break-even.